Downloads

1. Sample-Attribute-Based Selection Strategies For AAV %Full Determination 10/2/2026

   AAV %Full analysis must distinguish full, empty, and partial capsids, with complementary methods selected according to sample characteristics, analytical needs, development stage, and context.

2. DEA Reveals Hidden Costs Of Analytical Validation Guidelines 10/2/2026

   By treating distinct validation guidelines as decision-making units, data envelopment analysis (DEA) allows for the mathematical evaluation of their resource efficiency.

3. Qualification And Validation Of Depyrogenation Tunnels And Autoclaves 10/2/2026

   Systemic vulnerabilities exist in thermal uniformity assurance, steam penetration verification, regulatory fragmentation, and tech harmonization. 

4. Data-Centric Organoid Services For Predictive Drug Response And Next-Generation Oncology Research 10/1/2026

   Patient-derived organoids are gaining traction as translational tools in oncology, but their value depends on the quality and context of the data they generate, not the models alone.

5. Product Carbon Footprint: Enabling Product-Level Decarbonization In Biopharma 10/1/2026

   Facility-level and spend-based carbon accounting leave critical gaps in biopharma Scope 3 management. This whitepaper examines how batch-level product carbon footprinting changes what's measurable and what's actionable.

6. Accelerating CHO Media Development: From Screening To AI Design 10/1/2026

   Discover how high-throughput screening, process analytics, and AI-guided modeling can help identify promising CHO media and feed combinations faster and support a more predictive approach.

7. How EPR Unlocks Missing Dynamics In Pharma And Structural Biology Workflow 10/1/2026

   Uncover how EPR spectroscopy fills the conformational gap by capturing dynamic protein motions, refining Cryo-EM models, and revealing hidden structural ensembles for drug discovery.

8. FDA Modernizes Container Closure Guidance: What Is Changing And Why It Matters 10/1/2026

   The proposed revision reflects changes in packaging technology, drug delivery systems, quality risk management, and more that have occurred since 1999's guidance.

9. Engineering Better ADCs, Part 2: Characterization, CMC, And More 10/1/2026

   Let's take a closer look at antigen selection and tumor biology, PK and PD, analytical characterization, CMC, toxicity, and more.

10. The Experimental Truth Layer For AI-Native Drug Discovery 9/30/2026

    Protein dynamics can expose critical gaps between computational predictions and biological behavior. Learn how experimentally measuring conformational states can strengthen model validation.